Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Solid Tumor Cancer × tipiracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 9 Solid Tumor Cancer 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Neoplasm Metastasis 1 HER2 IHC3+ Advanced Colorectal Cancer 1 Colonic Neoplasms 1

Interventions

ispinesib 2 trifluridine tipiracil drug combination 1 tipiracil 1 Trifluridine 1 SB 743921 1 Interleukin-18 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492173 2026-03-25

Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans

Shandong New Time Pharmaceutical Co., LTD

Phase NA Completed

Other solid neoplasm

Solid Tumor Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡